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Abstract Porous conduits provide a protected pathway for
nerve regeneration, while still allowing exchange of nutri-
ents and wastes. However, pore sizes >30 µm may permit
fibrous tissue infiltration into the conduit, which may
impede axonal regeneration. Coating the conduit with
Fibrin Glue (FG) is one option for controlling the conduit’s
porosity. FG is extensively used in clinical peripheral nerve
repair, as a tissue sealant, filler and drug-delivery matrix.
Here, we compared the performance of FG to an alternative,
hyaluronic acid (HA) as a coating for porous conduits,
using uncoated porous conduits and reverse autografts as
control groups. The uncoated conduit walls had pores with a
diameter of 60 to 70 µm that were uniformly covered by
either FG or HA coatings. In vitro, FG coatings degraded
twice as fast as HA coatings. In vivo studies in a 1 cm rat
sciatic nerve model showed FG coating resulted in poor
axonal density (993 ± 854 #/mm2), negligible fascicular
area (0.03 ± 0.04 mm2), minimal percent wet muscle mass
recovery (16 ± 1 in gastrocnemius and 15± 5 in tibialis
anterior) and G-ratio (0.73± 0.01). Histology of FG-coated
conduits showed excessive fibrous tissue infiltration inside
the lumen, and fibrin capsule formation around the conduit.
Although FG has been shown to promote nerve
regeneration in non-porous conduits, we found that as a
coating for porous conduits in vivo, FG encourages scar
tissue infiltration that impedes nerve regeneration. This is a




Synthetic nerve conduits are often used to support periph-
eral nerve regeneration [1]. Mechanical properties such as
flexibility and kink resistance, are important parameters
while considering the design specifications of a synthetic
conduit [2]. In addition, the porosity and permeability of a
nerve conduit are also important [3]. The conduit walls can
either be fabricated as non-porous or porous. Non-porous
conduits work well when bridging smaller nerve gaps (<1
cm) while porous nerve conduits are particularly useful for
long nerve gap repair because they allow diffusion of




1 New Jersey Center for Biomaterials, Rutgers-The State University
of New Jersey, 145 Bevier Road, Piscataway, NJ 08854, USA
2 School of Pharmacy, University of Wyoming, 1000 E University
Ave Dept. 3375, Laramie, WY 82071, USA
Electronic supplementary material The online version of this article
(doi:10.1007/s10856-017-5889-4) contains supplementary material,
which is available to authorized users.
It is known that the conduit wall porosity can impact
nerve re-growth [7, 8]. Numerous studies have investigated
conduit porosity in the context of peripheral nerve regen-
eration and reported contradictory results [9–11]. Increased
porosity in the conduit walls may enhance permeability to
nutrients, and this may potentially augment nerve regen-
eration [3]. However, larger pores (>30 µm) can also permit
fibrous tissue infiltration and outward diffusion of growth
factors from within the conduit lumen that can potentially
suppress nerve regeneration [10, 12–15]. Therefore,
optimizing the degree of conduit wall porosity is an
essential step that requires the prevention of scar tissue
infiltration while allowing inward diffusion of nutrients
[16]. PLGA solution has been used to dip-coat braided
PLGA nerve conduits in an attempt to reduce their pore
size [17]. However, this attempt to reduce the conduit
macropores failed to improve nerve regeneration. Clements
et al. applied electrospun fiber mats made from tyrosine-
derived polycarbonates, with hyaluronic acid (HA) hydro-
gel coating, to the conduit walls to reduce the pore size of
braided conduits. They demonstrated that only the HA
hydrogel barrier coatings, but not the electrospun fiber
coatings, were effective in controlling the pore size of the
conduits leading to improved functional nerve recovery
in vivo [8].
Fibrin Glue (FG) has been used clinically as a tissue
sealant in peripheral nerve repair for over four decades [18–
22]. Reported benefits include decreased operative time
[20], maintenance of correct fascicular orientation [23],
improved gross surgical results [20], and minimal neural
scarring with reduced fibrosis and inflammation [24]. It is
also used widely experimentally, e.g., for stabilizing nerve
repairs and for delivering neurotrophic factors [25–29]. In a
recent in vivo mouse model study, FG sealant was found to
reduce surgical repair time, enhance axonal regeneration
and functional recovery [30]. Despite these benefits, it has
been reported that there is some hesitancy to using it, due to
fibrin’s role in increasing scar formation and hence poten-
tially inhibiting nerve regeneration [23].
In addition to being used for nerve coaptation, FG has
also been used to stabilize non-porous nerve conduits
placed around the site of primary neurorhaphy to avoid
additional suturing. This use of FG as an adjunct to con-
ventional neuro-suturing resulted in better fiber alignment
and axonal regeneration [31]. FG has also been used
as a conduit material [32–36]. In addition, FG has been
used as a filler within the lumen of non-porous conduits
[37, 38], and as scaffolds to deliver growth factors for
nerve regeneration [39, 40]. To the best of our knowledge,
all the studies that used Fibrin Glue were done with
non-porous conduits up till now. Although, FG is con-
sidered to be useful in nerve repair surgery, its utility in
conjunction with porous conduits has not been investigated.
In this study, we investigated the effectiveness of clinically
used FG as a hydrogel coating for braided porous nerve
conduits and compared it to the effectiveness of crosslinked
HA coatings, uncoated porous conduits, and autograft
repairs.
2 Materials and methods
2.1 Fabrication of braided conduits
The braided nerve conduits were fabricated using a
tyrosine-derived polycarbonate (TyrPC) abbreviated as
E1001(1k). This is a terpolymer composed of 10 mol%
desaminotyrosyl tyrosine (DT), and 1 mol% poly(ethylene
glycol) (PEG) of molecular weight 1 kDa; the remainder of
89 mol% is desaminotyrosyl tyrosine ethyl ester (DTE). A
polymer with a weight average molecular weight of 333
kDa was synthesized using previously published procedures
[41]. Briefly, the DTE and desaminotyrosyl-tyrosine tert-
butyl ester (DTtBu) were copolymerized with a pre-
determined molar equivalent of PEG under anhydrous
conditions using bis(trichloromethyl) carbonate (tri-
phosgene), followed by selective and quantitative removal
of the tert-butyl ester protecting groups using trifluoroacetic
acid (TFA) [42].
Braided conduits were fabricated using previously pub-
lished procedures [8]. Briefly, E1001(1k) powder was melt-
extruded into 80–110 µm diameter fibers on a Randcastle
microextruder (Cedar Grove, NJ). The fibers were braided
into a tubular conduit over a 1.5 mm diameter Teflon
mandrel (Applied Plastics Co., Inc., Norwood, MA) using a
tubular braiding machine (ATEX, Technologies Inc.,
Pinebuff, NC). The braiding parameters used were as fol-
lows: three filaments per yarn; 24 carriers, three twisted
fibers/carrier, and traditional 2-over-2 braid. The conduits
had an inner diameter of 1.5 mm, and the conduit walls had
a uniform pore size distribution of about 65± 19 µm. The
conduits were then cleaned by sonication in cyclohexane
(1x), followed by 0.5% (v/v) Tween20 in DI water (1x) and
lastly washing in DI water (5x). The cleaned conduits were
vacuum dried overnight at room temperature. Finally, they
were cut to 1.2 cm length with a thermal cutter and sterilized
under UV light for 45 min.
2.2 Hydrogel coatings
The braided conduits were coated with FG (Reagent Pro-
teins, San Diego, CA) or HA (Glycosan Biosystems-Bio-
Time, Inc. Alameda, CA). All the coating steps
(Supplementary Fig. 1) were carried out aseptically. To coat
with FG, the conduits were dipped once in a 1:1 mixture of
fibrinogen (F) and thrombin (T) (150 µl of 50 Units/ml
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Thrombin and 150 µl of 50 mg/ml Fibrinogen) to achieve a
~200–250 μm thick coating. FG-coated conduits were dried
overnight in a laminar flow hood before being used for
implantation. To apply HA, conduits were coated by dip-
ping in 1% (w/v) sterile thiol-modified hyaluronan solution
for 30 s followed by crosslinking in 1% (w/v) poly(ethylene
glycol diacrylate) (PEGDA) solution for 30 s. These steps
were repeated 20 times to achieve a ~150–200 µm thick HA
coating. After the 20th layer, the conduits were dipped in
sterile hyaluronan solution for 30 s and then dried overnight
in a laminar flow hood before being used for implantation.
The optimized processing parameters for the HA and FG
coating were selected after performing various iterations as
shown in Supplementary Table 1.
2.3 Scanning electron microscopy (SEM)
Conduits were imaged using scanning electron microscopy
(SEM, Amray 1830I, 20 kV) after sputter coating with Au/
Pd (SCD 004 sputter coater, 30 milliamps for 120 s). Pore
size, thickness and uniformity of the coating were assessed
on SEM images using Image J (software from National
Institutes of Health). Coating thickness was calculated by
subtracting the wall thickness of the uncoated conduit from
the wall thickness of the coated conduit. Uniformity of the
coating was assessed qualitatively. The coatings were con-
sidered to be ‘uniformly covering the pores’ when the pores
between the 2-over-2 braids in the coated conduits were no
longer visible in the SEM images.
2.4 In vitro degradation of the hydrogel coatings
Degradation of the hydrogel coatings was followed over a
16-week period in vitro. Coated conduits (n= 3 per time
point) were incubated in phosphate buffered saline (PBS;
Life Technologies, NY, USA) at 37 °C for 1, 2, 4, 6, 8, 12
and 16 weeks. The coated conduits were air dried at room
temperature and weighed over the 16-week study period.
The percent weight loss of the hydrogel coatings was
determined as WfWiWi
   100, where Wi is the initial conduit
weight prior to incubation, and Wf is the conduit weight at a
particular time point. Dehydrated conduits at 1, 2, 4 and
6 weeks were also imaged using SEM to determine the
integrity of the coatings.
2.5 Mechanical characterization of the hydrogel coated
conduits
Compression and three-point bending tests were performed
to evaluate the mechanical properties of the braided
hydrogel-coated conduits using a Syntec 5/D mechanical
tester (MTS, Eden Prairie, MN). 1 and 1.5 cm long hydrogel
coated conduits (n= 3 for each test) were incubated in PBS
at 37 °C overnight and were tested immediately after
removal from the incubator. The parameters used for the
compression tests were: Conduit length= 1 cm, transverse
crosshead speed= 6 mm/min; endpoint displacement=
60% of initial conduit diameter. Compressive structural
stiffness was calculated from the slope of the linear region
in the force vs. displacement curves. For 3-point bending
tests, 1.5 cm long conduits (n= 3) were placed on the
bending fixture over two roller pins that were 1 cm apart.
The load was applied on a third pin located midway along
the conduit at a crosshead speed of 10 mm/min. The slope
determined by linear regression of the linear part of the
force-displacement (F-d) curve was used to calculate
bending stiffness. The results from three different coated
conduits were averaged.
2.6 In vivo evaluation
2.6.1 Surgical methods and groups
Nerve regeneration was evaluated in vivo in a 1 cm rat
sciatic nerve injury model over a 16-week period. All
experiments were conducted using protocols approved by
the Rutgers Institutional Animal Care and Use Committee
(IACUC). Twenty-four female Lewis rats (225–250 g) were
randomly assigned to four groups: Uncoated, FG-coated,
and HA-coated nerve conduits; and reverse autografts (n=
6 animals per group). The rats were anesthetized with iso-
flurane. The left sciatic nerve was exposed, and a 1 cm gap
was created, 2 mm distal to the external obturator tendon.
Sterile uncoated, HA-coated and FG-coated nerve conduits
(1.2 cm long× 1.5 mm ID) were sutured to the distal and
proximal nerve stumps using 9–0 nylon perineurial sutures
(Ethicon, NJ, USA). For reverse autograft controls, the 1 cm
nerve segment was reversed and sutured back into the same
gap using 9–0 nylon sutures. The muscles and skin were
closed using 6–0 Vicryl and nylon sutures respectively
Table 1 Compressive structural
stiffness and bending stiffness of
the uncoated conduit compared
to the HA-coated and FG-coated
conduit (mean ± SD of the three
samples tested)
Uncoated conduit HA coated conduit FG-coated conduit
Compressive structural stiffness (N/mm) 23± 2 28± 3 30± 5
Bending stiffness (EI, Nmm2) 15± 5 15± 3 17± 3
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(Ethicon, NJ, USA). Skin sutures were removed 10 days
after surgery.
2.6.2 Nerve conduction study
Peroneal and tibial electromyography (EMG) was per-
formed to determine compound muscle action potential
(CMAP) area and latency distal to the nerve injury (Viking
Quest, CareFusion, San Diego, CA), as published pre-
viously [43]. The average of three consecutive recordings of
the CMAP area and the latency were measured for each
animal preoperatively, and then postoperatively at 4, 8, 12
and 16 weeks. The results were averaged for the animals in
each treatment group.
2.6.3 Nerve histomorphometry and wet muscle mass
At the 16-week study endpoint, rats were anesthetized using
isoflurane and the nerve was fixed in situ by filling the
muscle pocket with Trump’s fixative (Electron Microscopy
Sciences, Hatfield, PA) for 30 min. The tissue specimen
(conduit/autograft including at least 3 mm of the proximal
and distal nerve) were explanted and further fixed in
Trump’s fixative for 4 days. The midsection of the conduit
was post-fixed with osmium tetroxide, embedded in epoxy
resin, cut into 1 μm thick sections and stained with toluidine
blue. Images were acquired using a microscope at 50×,
400× and 1000× magnification and total myelinated area,
axonal to fiber diameter (G-ratio), and axonal density for
each group was calculated using Image J. After harvesting
the nerve specimens, animals were sacrificed by CO2
asphyxiation and the tibialis anterior (TA) and gastro-
cnemius (Gastroc) muscles from both ipsilateral and con-
tralateral sides of the hind leg were removed and
immediately weighed to assess wet muscle mass.
3 Results
3.1 Conduit fabrication and hydrogel coatings
The polymer identified as E1001(1k) was chosen from a
library of tyrosine-derived polycarbonates to fabricate the
braided porous conduits used in this study. The specific
batch of E1001(1k) utilized in this study had a poly-
dispersity (PDI) of 1.6, a glass transition temperature (Tg) of
97 °C and a resorption period of ~18 months [44]. Extruded
and oriented fibers with a diameter of about 80–110 µm
were used to fabricate braided conduits using a 2-over-2
braid pattern. HA and FG hydrogels were prepared and
applied as a coating on the outer side of the conduits. SEM
micrographs (Fig. 1a) of the uncoated conduit show large
open pores (65± 19 µm dia.) that were completely covered
after coating. The coatings were considered to be uniform
when no open pores could be visualized on SEM images.
The average thickness of the HA coatings was ~160± 20
µm, and of the FG coatings was ~200 ± 25 µm.
3.2 In vitro degradation and mechanical
characterization of the hydrogel coated conduits
There was no noticeable degradation of the fibers in the
conduit walls, which is expected given the 18 month
resorption period of E1001(1k). SEM micrographs (Fig. 1b)
showed that the HA and FG hydrogel coatings were
structurally intact, and the macropores remain uniformly
covered for 6 weeks in PBS (Fig. 1b). However, the FG
coating degrades faster than the HA coating: at 16 weeks,
there is >50% loss of the FG coating, compared to 20% loss
of the HA coating (Fig. 1c). Mechanical properties of the
uncoated and coated braided conduits were also evaluated
by transverse compressive load-displacement analysis and
three-point bending tests. Our results (Table 1) show that
the coated conduits have a slightly higher compressive
structural stiffness, but similar bending stiffness as the
uncoated conduits.
3.3 In vivo evaluation
3.3.1 Scar tissue response and histomorphometric analysis
at 16 weeks
After fixation, and embedding of the explanted conduits,
they were sectioned into 1 µm-thick slices and stained with
osmium tetroxide and toluidine blue. Histological evalua-
tion of the HA-coated and FG-coated nerve conduit sections
demonstrated a marked difference in tissue composition at
16 weeks (Fig. 2). The regenerated nerves within uncoated
braided conduits were poorly organized (Fig. 2a). The nerve
cable contained numerous myelinated axons, but these were
dispersed, instead of constituting well-defined fascicles.
Myelinated axons were surrounded by fibrous tissue
(denoted by FT in the figure) that appeared to have impeded
the formation of a well-defined nerve cable surrounded by
epineurium.
Although the FG and HA hydrogel coatings cover the
pores of braided conduits in a similar manner in vitro (SEM
micrographs, Fig. 1a), they induce different types of cellular
infiltration in vivo. FG coating on the E1001(1k) conduits
not only failed to prevent the infiltration of scar tissue but
appeared to enhance it (Fig. 2b). There was no observable
axonal regeneration in FG-coated conduits. Figure 2b
demonstrates a thick capsule of scar tissue around the FG-
coated conduit.
In contrast to FG, the HA coating prevented the infil-
tration of non-nerve tissue and led to the formation of a
79 Page 4 of 10 J Mater Sci: Mater Med (2017) 28:79
densely packed nerve cable with a high density of myeli-
nated axons (Fig. 2c). The nerve cable was surrounded by a
well-defined epineurium, characteristic of healthy regen-
eration, and similar to that seen with autograft. Autografts
(Fig. 2d) indeed showed numerous myelinated axons in a
well-defined epineurium.
Histomorphometric analysis was performed using 1000×
images to compare the morphology of the regenerating
axons and the myelin sheath. Total surface area of the
axonal tissue, the density of myelinated nerve fibers and the
G-ratio were calculated using Image J. FG-coated conduits
had the lowest axonal density while HA-coated conduits
and autografts had a very high axonal density (Table 2).
FG-coated conduits had the lowest fascicular area due to a
low density of myelinated axons compared to autografts and
HA coated nerve conduits. G-ratio (axon/fiber diameter)
was highest in the FG-coated conduits, indicating less
myelination. G-ratio of the autografts and HA-coated con-
duits were close to the normal value of healthy nerves (0.6),
an optimal value for the transmission of current from one
node of Ranvier to the next [45].
3.3.2 Wet muscle mass and functional recovery
The percent wet muscle mass recovery for gastrocnemius
and tibialis anterior muscles was calculated as (Ipsilateral
muscle mass/Contralateral muscle mass) *100 at 16 weeks
(Table 3).
Rats implanted with FG-coated conduits had the lowest
muscle weight compared to highest muscle weight in
autologous implants, followed by HA-coated conduits and
then uncoated conduits.
To assess the extent of functional regeneration, we
measured the peroneal and tibial CMAP area (Fig. 3a and b)
and latency (Fig. 3c and d), pre-operatively and post-
operatively over the 16-week period. Autografts had faster
and more complete functional recovery than nerves that
regenerate in conduits (Fig. 3a and b). In autografts, initial
nerve conduction and CMAP area recovery was seen at
week 8 as compared to week 12 for HA-coated conduits and
uncoated conduits. There was no CMAP recovery for any of
the FG-coated conduits, even at week 16 (Fig. 3a and b).
This corroborates the histological findings described above
Fig. 1 a SEM micrographs of the longitudinal view of the uncoated,
HA and FG-coated conduits. An average pore size for uncoated con-
duits of 65± 19 µm was measured by Image J. After coating with
either HA or FG, the coatings covered the macropores of the braided
conduits, and no open pores were visible by SEM. [Scale bar= 100
µm]. b SEM micrographs of the HA and FG hydrogel coating after
6 weeks. The hydrogel coatings remain structurally intact at 6 weeks
when compared to day 0. Scale bar= 100 µm c Weight (in percent of
initial weight) of hydrogel coating remaining on the conduit surface
after in vitro degradation over 16 weeks
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Fig. 2 Toluidine blue stained 1 μm-thick cross sections of the conduits
explanted after 16 weeks in vivo. 50× images show entire conduit and
nerve cable (dark stain) [Scale bar= 200 µm], 400× images show the
interface between axonal tissue and surrounding inter-luminal area
[Scale bar= 50 µm] and 1000× images represent the 1 µm-thick nerve
mid-segments post-fixed with osmium tetraoxide for a Uncoated b
FG-coated (very few myelinated axons present in some cases) c HA-
coated (high density of myelinated axons) d Autologous. [Scale bar=
10 µm]. (FT fibrous tissue, Ep Epineurium, C Conduit, L lumen, FC
fibrous capsule, NC nerve cable)
Table 2 Nerve histomorphometry of the four comparative groups:
Average density of the myelinated nerve fibers: Axonal Density
(#/mm2); The total surface area of the axonal tissue: Fascicular area







Autologous 6460± 362 0.36± 0.08 0.64± 0.02
Uncoated 5382± 428 0.15± 0.02 0.69± 0.02
FG-coated 993± 854 0.03± 0.04 0.73± 0.01
HA-coated 7130± 306 0.17± 0.04 0.66± 0.02
Data are represented as mean± SE
Table 3 Percent wet muscle mass recovery at the end of 16 weeks for





Autologous 60± 6 69± 4
Uncoated 34± 3 42± 2
FG-coated 16± 1 15± 5
HA coated 50± 2 60± 3
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for the FG-coated conduits (Fig. 2). Figure 3c and d shows
normal latencies pre-operatively, which were never fully
regained after injury. Distal latency for the autografts was
detected at week 8 and for the HA conduit group and
uncoated conduits at week 12. Even at 16 weeks, no latency
could be measured for the FG-coated conduits.
4 Discussion
Fibrin Glue is one of the most extensively used materials in
peripheral nerve regeneration. Conduits fabricated from
fibrin have been demonstrated to increase axonal growth
compared to a poly-3-hydroxybutyrate (PHB) conduit [46],
and to promote regeneration of up to 86% myelinated axons
when compared to a nerve graft in a 1 cm rat sciatic nerve
model [47]. As a filler and scaffold within the non-porous
conduits, fibrin glue has been used for encapsulating and
delivering mesenchymal stem cells in a non-porous poly
(caprolactone) (PCL) conduit [48]. In another study, Ma
et al. successfully used non-porous silicone tubes filled with
nerve growth factor (NGF) - FG mixtures to repair a 1.5 cm
rat sciatic nerve gap [49]. The most frequent use of fibrin
glue has been as a tissue sealant for nerve coaptation [24].
Several studies have shown the potential benefits of using
fibrin glue compared with microsuturing [50, 51]. Isaacs
et al. showed that fibrin glue holds the nerve ends, main-
taining the overall alignment and providing a barrier from
intervening scar tissue [52]. Since fibrin glue is so widely
and successfully used for non-porous nerve conduits in
various forms, it encouraged us to explore its use for porous
nerve conduits.
Braiding introduces porosity in the nerve conduit wall [8,
17, 53–55]. Gao et al. showed that braided nerve conduits
made of filaments of poly(L-lactide-co-glycolide) (PLGA)
were highly porous (pore size between 50–100 µm) [54].
The uncoated E1001(1k) braided nerve conduits used in this
study also had large open pores (65 ± 19 µm dia.) (Fig. 1).
Considering that non-neural cells can easily penetrate
through the large pores of these braided nerve conduits, in
this study, we investigated the use of fibrin glue as a
hydrogel coating to cover these pores. FG uniformly cov-
ered the pores of the uncoated E1001(1k) nerve conduit and
was intact in vitro until 6 weeks. However, by 16 weeks, FG
coating had degraded >50%.
Mechanical properties of a nerve conduit are critical for
the conduit to maintain its integrity, stability at the implant
site [56] and to resist against the compression caused by the
Fig. 3 Electrophysiological measurements pre and post-op. every 4 weeks till 16 weeks. CMAP area a Peroneal b Tibial; CMAP Latency: c
Peroneal and d Tibial nerve
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surrounding tissues, muscular contraction, and deformation
[57]. Our mechanical tests suggested that the hydrogel
coatings slightly increased the compressive structural stiff-
ness of the conduits but the bending stiffness remained the
same as for the uncoated porous conduits.
Histology of the regenerated nerves within the conduits
strongly indicated that FG coating on the E1001(1k) con-
duits not only failed to prevent the infiltration of scar tissue
but appeared to enhance it. Formation of a thicker capsule
of tissue around the FG-coated conduits than the HA-coated
ones suggests that the FG coating may be attracting the
fibroblasts present in the conduit periphery. A similar
fibrous capsule outside the conduit and fibrous tissue
infiltration were also reported in bi-component electro-
spun conduits [43]. Fibrous tissue infiltration was also
reported in commercial collagen nerve tubes, which
failed to regenerate nerves [58]. Histology of the midseg-
ment of their explanted collagen conduits confirmed
the formation of fibrous scar tissue, which resulted in a
disorganized neural architecture and very little axonal
regeneration. During the period of nerve regeneration,
axons begin to regenerate from the proximal towards
the distal ends, and Schwann cells start to migrate into
the conduit lumen [59]. The infiltration of fibrous tissue as
seen in the uncoated conduits, and in conduits with FG
coating, can impede neural regeneration, misdirect
axons, and interfere with the maturation of sprouting axons
[60]. Results from the histomorphometric analysis con-
firmed that FG coatings fail to prevent infiltration of non-
nerve tissue.
Denervation of the target muscle is also an indication of
peripheral nerve injury [61]. As the nerve regenerates into
the muscle, the neuromuscular junction is restored, and the
muscle regains its mass in proportion to the degree of
reinnervation [62]. The lower degree of wet muscle mass
recovery with FG-coated conduits indicated poorer nerve
regeneration. This finding was also corroborated by the
histological and the histomorphometric findings.
Electrophysiological findings over 16-weeks indicated
decreased CMAP areas in the animals implanted with FG-
coated conduits. CMAP area is proportional to the number
of motor axons stimulated and hence, correlates with the
number of regenerated axons [63]. As a complementary
measure to amplitude, CMAP latencies are indicative of
nerve conduction velocity, and correlate with the level of
axonal myelination and nerve regeneration. Decreased
latencies are indicative of faster conduction velocity
and improved recovery [64]. Even at 16 weeks, no latency
could be measured in animals with FG-coated conduits,
indicating very little, if any, nerve regeneration. These
electrophysiological recovery assessments are in line with
wet muscle mass and histomorphometric results.
5 Conclusions
Considering the wide use of FG as a tissue sealant in nerve
repair, the results of our study are unexpected. FG per-
formed poorly when used as a coating for porous braided
conduits. Our results indicate that a FG coating on a porous
conduit appears to attract non-neural cells. Instead of pre-
venting the infiltration of scar tissue into the lumen of the
conduit, the presence of a FG coating seemed to facilitate it.
Consequently, FG coatings resulted in poor axonal regen-
eration and functional recovery. We conclude that although
FG has been successfully used in conjunction with non-
porous conduits to facilitate peripheral nerve regeneration,
its use as a coating on porous conduits impedes functional
nerve regeneration. In contrast, our results indicate that HA
coatings are more effective than FG coatings in preventing
scar tissue infiltration into the lumen of porous conduits.
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